Jeff M. Michalski

3.8k total citations · 1 hit paper
20 papers, 937 citations indexed

About

Jeff M. Michalski is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeff M. Michalski has authored 20 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeff M. Michalski's work include Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (9 papers) and Cancer Research and Treatments (5 papers). Jeff M. Michalski is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (9 papers) and Cancer Research and Treatments (5 papers). Jeff M. Michalski collaborates with scholars based in United States, United Kingdom and Netherlands. Jeff M. Michalski's co-authors include Anthony L. Zietman, Roger Chou, Jeffrey M. Holzbeierlein, Joshua J. Meeks, Yair Lotan, Ashish M. Kamat, Jonathan E. Rosenberg, Seth P. Lerner, Diane Zipursky Quale and Todd M. Morgan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

Jeff M. Michalski

20 papers receiving 924 citations

Hit Papers

Treatment of Non-Metastatic Muscle-Invasive Bladder Cance... 2017 2026 2020 2023 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
    2017 613 citations Sam S. Chang, Bernard H. Bochner et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff M. Michalski United States 8 805 287 238 217 62 20 937
Ataru Sazawa Japan 18 549 0.7× 192 0.7× 156 0.7× 246 1.1× 123 2.0× 47 831
Florian Janisch Germany 18 556 0.7× 130 0.5× 190 0.8× 305 1.4× 95 1.5× 40 802
Ricardo L. Favaretto United States 14 701 0.9× 176 0.6× 109 0.5× 324 1.5× 102 1.6× 24 839
Reinhard Kühn Germany 16 870 1.1× 423 1.5× 198 0.8× 370 1.7× 149 2.4× 49 1.2k
Khaled Hafez United States 12 459 0.6× 181 0.6× 142 0.6× 196 0.9× 137 2.2× 32 655
J. Casanova Spain 17 761 0.9× 371 1.3× 107 0.4× 341 1.6× 166 2.7× 79 1.1k
Jesús Moreno Sierra Spain 14 302 0.4× 134 0.5× 168 0.7× 277 1.3× 89 1.4× 117 649
A. Garbeglio Italy 13 740 0.9× 279 1.0× 211 0.9× 451 2.1× 137 2.2× 27 1.2k
Kristin M. Sanderson United States 11 416 0.5× 232 0.8× 290 1.2× 178 0.8× 96 1.5× 14 857
Lars Christian Horn Germany 11 247 0.3× 172 0.6× 77 0.3× 342 1.6× 57 0.9× 13 625

Countries citing papers authored by Jeff M. Michalski

Since Specialization
Citations

This map shows the geographic impact of Jeff M. Michalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff M. Michalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff M. Michalski more than expected).

Fields of papers citing papers by Jeff M. Michalski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff M. Michalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff M. Michalski. The network helps show where Jeff M. Michalski may publish in the future.

Co-authorship network of co-authors of Jeff M. Michalski

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff M. Michalski. A scholar is included among the top collaborators of Jeff M. Michalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff M. Michalski. Jeff M. Michalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shuang, Hyunnam Ryu, J. Proudfoot, et al.. (2025). Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.. Journal of Clinical Oncology. 43(5_suppl). 308–308. 2 indexed citations
2.
Wisdom, Amy J., Beow Y. Yeap, Jeff M. Michalski, et al.. (2024). Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 121(3). 741–751. 3 indexed citations
3.
Gupta, Shilpa, Yasuhisa Fujii, Michiel Simon Van Der Heijden, et al.. (2024). Phase 3 KEYNOTE-992 study of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 42(4_suppl). TPS720–TPS720. 3 indexed citations
4.
Baumann, Brian C., S.G. Kohlmyer, Zachary L. Smith, et al.. (2023). ARTIA-Bladder: Daily Online Adaptive Short-Course Radiation Therapy (RT) and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer (MIBC): A Prospective Trial of an Individualized Approach for Reducing Bowel and Bladder Toxicity. International Journal of Radiation Oncology*Biology*Physics. 117(2). e366–e366. 2 indexed citations
5.
Fischer‐Valuck, Benjamin W., Sagar A. Patel, Randall Brenneman, et al.. (2022). Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy. European Urology Oncology. 5(2). 246–250. 6 indexed citations
6.
Shore, Neal D., Nicholas D. James, Michiel Simon Van Der Heijden, et al.. (2022). Abstract CT564: KEYNOTE-992: A randomized phase 3 trial of pembrolizumab versus placebo in patients with muscle-invasive bladder cancer receiving concurrent chemoradiotherapy. Cancer Research. 82(12_Supplement). CT564–CT564. 3 indexed citations
7.
Hanson, Ian, Hanneke Meijer, A. Bertelsen, et al.. (2021). MR-Guided Adaptive Radiotherapy for Bladder Cancer. Frontiers in Oncology. 11. 637591–637591. 34 indexed citations
8.
Weickhardt, Andrew, Michiel Simon Van Der Heijden, Arjun Vasant Balar, et al.. (2021). Pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus placebo plus CRT for patients (pts) with muscle-invasive bladder cancer (MIBC): The phase III KEYNOTE-992 study.. Journal of Clinical Oncology. 39(6_suppl). TPS508–TPS508. 1 indexed citations
9.
Dahl, Douglas M., Jennifer Rodgers, William U. Shipley, et al.. (2021). NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging. International Journal of Radiation Oncology*Biology*Physics. 111(3). S133–S134. 7 indexed citations
10.
Fischer‐Valuck, Benjamin W., Jeff M. Michalski, Joanna Harton, et al.. (2020). Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy. Clinical Genitourinary Cancer. 19(1). 41–46.e1. 2 indexed citations
11.
Balar, Arjun Vasant, Nicholas D. James, Shahrokh F. Shariat, et al.. (2020). Phase III study of pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus CRT alone for patients (pts) with muscle-invasive bladder cancer (MIBC): KEYNOTE-992.. Journal of Clinical Oncology. 38(15_suppl). TPS5093–TPS5093. 12 indexed citations
12.
Carmona, R., Loren K. Mell, Sriram Venigalla, et al.. (2019). The Integration of Clinical and Genomic Information Improves Risk Stratification for Locoregional Failure in Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(1). E250–E251. 1 indexed citations
13.
Brenneman, Randall, Benjamin W. Fischer‐Valuck, Hiram A. Gay, et al.. (2018). A Propensity Analysis Comparing Definitive Chemo-Radiation for Muscle-Invasive Adenocarcinoma of the Bladder Versus Urothelial Carcinoma of the Bladder using the National Cancer Database (NCDB). International Journal of Radiation Oncology*Biology*Physics. 102(3). e84–e85. 1 indexed citations
14.
Fischer‐Valuck, Benjamin W., Jeff M. Michalski, John P. Christodouleas, et al.. (2018). Effectiveness of adjuvant radiotherapy after radical cystectomy for locally advanced bladder cancer.. Journal of Clinical Oncology. 36(6_suppl). 484–484. 1 indexed citations
15.
Chang, Sam S., Bernard H. Bochner, Roger Chou, et al.. (2017). Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. The Journal of Urology. 198(3). 552–559. 613 indexed citations breakdown →
16.
17.
Merks, Johannes H. M., Gian Luca De Salvo, Christophe Bergeron, et al.. (2013). Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. Annals of Oncology. 25(1). 231–236. 58 indexed citations
18.
Diamond, David A., Jeff M. Michalski, John P. Lynch, & Elbert P. Trulock. (1998). Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. International Journal of Radiation Oncology*Biology*Physics. 41(4). 795–800. 55 indexed citations
19.
Chao, C., Peter P. Lai, Jeff M. Michalski, & Carlos A. Perez. (1995). Secondary malignancy among seminoma patients treated with adjuvant radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 33(4). 831–835. 24 indexed citations
20.
Myerson, Robert J., Jeff M. Michalski, Elisa H. Birnbaum, et al.. (1995). Adjuvant radiation therapy for rectal carcinoma: Predictors of outcome. International Journal of Radiation Oncology*Biology*Physics. 32(1). 41–50. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ataru Sazawa Breakdown of academic impact, for papers by Florian Janisch Breakdown of academic impact, for papers by Ricardo L. Favaretto Breakdown of academic impact, for papers by Reinhard Kühn Breakdown of academic impact, for papers by Khaled Hafez Breakdown of academic impact, for papers by J. Casanova Breakdown of academic impact, for papers by Jesús Moreno Sierra Breakdown of academic impact, for papers by A. Garbeglio Breakdown of academic impact, for papers by Kristin M. Sanderson Breakdown of academic impact, for papers by Lars Christian Horn
Rankless by CCL
2026